Atlas Trials

Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange

Clinical trial NCT02095821 · TERMINATED

Trial details

NCT number
NCT02095821
Sponsor
Hannover Medical School
Status
TERMINATED
Study type
OBSERVATIONAL
Clotting Disorder Due to Plasma Exchange TherapyHumoral Rejection After Kidney Transplantation
Start date
2014-02-01
Primary completion
2019-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.